Source: DGNews | Posted 8 years ago
FDA Grants Approvable Letter for Lexapro (Escitalopram Oxalate), Treatment of Generalized Anxiety Disorder
Tags:
NEW YORK, NY -- September 29, 2003 -- Forest Laboratories, Inc. (NYSE: FRX) announced today that it has received an approvable letter from the United States Food and Drug Administration (FDA) to expand the use of Lexapro
Comments